Patent ID: 11897961
Assignee: IMMUNOGEN, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The immunoconjugate of claim 1, wherein the antibody or antigen-binding fragment thereof comprises:
a) an immunoglobulin heavy chain variable region (VH) having the amino acid sequence set forth in SEQ ID NO: 39 or 40; and b) an immunoglobulin light chain variable region (VL) having the amino acid sequence set forth in SEQ ID NO: 41; or
a) an immunoglobulin heavy chain variable region (VH) having the amino acid sequence set forth in SEQ ID NO: 34; and b) an immunoglobulin light chain variable region (VL) having the amino acid sequence set forth in SEQ ID NO: 35; wherein Xaa, the second residue from the N-terminus of SEQ ID NO: 34, is Phe or Val.